Why did Schrodinger (SDGR) stock move recently?

On 8/25/2026, Schrodinger moved +6.5% — No specific company catalyst or news identified for the move; SDGR rose with broader market or sector sentiment. This is MarketChacha's decoded reason from filings and credible news; it is education, not buy/sell advice.

Is Schrodinger (SDGR) overvalued or fairly valued?

MarketChacha shows Schrodinger's valuation in context — a forward P/E of about -14.9, a price-to-book of about 4.5 — alongside its revenue and profit growth and whether reported profit converts into operating cash, so you can judge value for yourself. MarketChacha does not issue ratings, price targets, or buy/sell advice.

What is Schrodinger's revenue?

Schrodinger reported revenue of $255.9M for FY2025, with net profit of $-103.3M, per official filings.

What is the share price of Schrodinger (SDGR)?

Schrodinger last traded at $20.09 (-3.0% on the day), as of 9/4/2026 — a delayed quote shown for education, not investment advice.

Schrodinger

SDGR · NYSE · Healthcare · United States

Snapshot

TickerSDGR

ExchangeNYSE

SectorHealthcare

IndustryHealth Information Services

CountryUnited States

Employees850

HeadquartersNew York, United States

Websitewww.schrodinger.com

Filings tracked16

About Schrodinger

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Who owns it

Insiders3.0%
Institutions96.7%
Public & other0.3%

322 institutional holders

Ownership breakdown from public market data.

Top holders

Blackrock Inc.16.05%
Gates Foundation Trust10.65%
Rubric Capital Management LP9.76%
Vanguard Portfolio Management LLC5.78%
Sumitomo Mitsui Trust Group, Inc.4.13%
Amova Asset Management Americas Inc4.13%
Vanguard Capital Management LLC4.11%
State Street Corporation3.51%

Largest institutional holders — last updated 6/30/2026.

Forensic scorecard

Margin has compressed by about 59.2 points over the period — profitability is trending down.

Net margin trend18.8% → -40.4%

Margin has compressed by about 59.2 points over the period — profitability is trending down.

Return on equity-28.4%

Latest ROE of -28.4% is on the low side — the business earns a modest return on shareholder capital.

Computed by MarketChacha from reported figures (SEC XBRL). Education, not a rating or recommendation.

What's expected next

Next quarter

Rev $74.7M · EPS -0.16

Est. earnings growth +11.2%

Next fiscal year

Rev $250.3M · EPS -1.35

Est. earnings growth +26.2%

Analyst consensus estimates — not the company's own guidance.

New to these terms?

P/E ROE ROCE Margins Market cap

Browse the Learn hub →

Financials at a glance

Source: SEC XBRL

Annual

Quarterly · last 8

Revenue (FY2025)

$255.9M

Net margin

-40.4%

ROE

-28.4%

Revenue CAGR (2y)

+8.7%

EPS (FY2025)

-1.41

Net profit (FY2025)

$-103.3M

Ask MarketChacha about SDGR

Get a cited, plain-English answer — the “why”, not just data. Finance research only, never buy/sell advice.

Why it moved

Aug 25, 2026
No specific company catalyst or news identified for the move; SDGR rose with broader market or sector sentiment.
· confidence: low

Daily moves with the verified reason behind them. Education only — not investment advice.

Financials

Yearly

Period	Revenue	Net profit	EPS	Net margin	ROE
FY2025	$255.9M	$-103.3M	-1.41	-40.4%	-28.4%
FY2024	$207.5M	$-187.1M	-2.57	-90.2%	-44.4%
FY2023	$216.7M	$40.7M	0.54	18.8%	7.4%

Quarterly

Period	Revenue	Net profit	EPS	Net margin
2026Q2	$58.9M	$6.0M	0.08	10.1%
2026Q1	$58.6M	$-60.0M	-0.81	-102.5%
2025Q3	$54.3M	$-32.8M	-0.45	-60.4%
2025Q2	$54.8M	$-43.2M	-0.59	-78.8%
2025Q1	$59.6M	$-59.8M	-0.82	-100.4%
2024Q3	$35.3M	$-38.1M	-0.52	-108.1%
2024Q2	$47.3M	$-54.0M	-0.74	-114.2%
2024Q1	$36.6M	$-54.7M	-0.76	-149.5%
2023Q3	$42.6M	$-62.0M	-0.86	-145.7%
2023Q2	$35.2M	$4.3M	0.06	12.2%
2023Q1	$64.8M	$129.1M*	1.75	—

* Net profit includes one-off / non-operating items (e.g. a settlement or accounting gain), so it doesn’t reflect operating performance — net margin is hidden for that period.

Figures as reported, in reporting currency. Source: SEC XBRL.

Filings & announcements

2026

8-K — Results of operations, Exhibits
SEC8/5/2026material
10-Q filing
SEC8/5/2026
8-K — Reg FD disclosure
SEC6/29/2026material
8-K — Executive/director change, Shareholder vote results, Exhibits
SEC6/23/2026material
8-K — Executive/director change, Exhibits
SEC6/8/2026material
8-K — Executive/director change, Reg FD disclosure
SEC5/20/2026material
8-K — Results of operations, Exhibits
SEC5/5/2026material
10-Q filing
SEC5/5/2026
8-K — Executive/director change
SEC3/12/2026material
8-K — Results of operations, Exhibits
SEC2/25/2026material
10-K filing
SEC2/25/2026

2025

8-K — Results of operations, Exhibits
SEC11/5/2025material
10-Q filing
SEC11/5/2025
8-K — Executive/director change, Exhibits
SEC9/8/2025material
8-K — Results of operations, Exhibits
SEC8/6/2025material
10-Q filing
SEC8/6/2025

In the news

Education and discussion only — not investment advice. Financials from official filings (SEC/BSE) and reported company statements; market figures (delayed market data) are delayed and shown for reference only. Verify with the linked sources before acting.